Cargando…
Glucokinase activators (GKAs) promise a new pharmacotherapy for diabetics
The glucose-phosphorylating enzyme glucokinase, a promising target for developing new antidiabetic agents, was identified through the combined efforts of basic research and human biochemical genetics. Allosteric glucokinase activators (GKAs) were discovered by high-throughput screening of a large co...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medicine Reports Ltd
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950051/ https://www.ncbi.nlm.nih.gov/pubmed/20948841 http://dx.doi.org/10.3410/M2-43 |